TX
10x Genomics Inc. Class A
TXG · 10x Genomics Inc. Class A · Industrials
Up next day
8/12
67%
Fell despite growth
3/12
Good earnings ignored
Avg earnings move
±5.9%
typical swing on earnings
Price when beating
+3.1%
avg over 10 beats
Biggest single move
+17.3%
'25.9 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Good results usually push the stock up
Up the next day 7 of 10 beats (70%)
Reaction is erratic and hard to predict
Avg +3.1% on a beat, +4.1% on a miss
Tends to keep drifting the same way for days
Day-one direction continued · 75% of last 12
vs Industrials sector avg (197 peers)
This
+3.2%
Sector
+0.5%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
This stock mostly moves with the reported earnings number
Moved opposite to results 4 of last 12 times (33%)
3xBeat but fell
Even a beat sells off if guidance disappoints
1xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Nov 5After close
'26.9 expectedEst. EPS $-0.02
Quarter ended 6/2026
Reported 2026-08-06
Next-day move
+14.1%
After 5 days +27.5%
vs Consensus$-0.02→$0.03+258.4% beat
EPS
$0.03
YoY -94%
Revenue
$0.2B
YoY -13%
Next-Q guidance
—
N/A
Price around earnings
Rose despite missvs market +13.5%p3.1x normal — unusual surge+101% run-up before
Earnings trend · last 12 quarters
EPS$0.03YoY -94%
'23.9'26.6
Revenue$0.2BYoY -13%
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
4x33%
Met expectations
good · up ↑
4x33%
Disappointment
weak · down ↓
2x17%
Good earnings ignored
good · down ↓
2x17%
← ← Weak earningsStrong earnings → →
Price rose even on weak earnings — bad news priced in / buy-the-dip · 4 of 12q (33%)
Community · TXG
What do you think of this stock's earnings pattern?
···